| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 146, Issue 7 2345-2351, Copyright © 1991 by American Association of Immunologists
ARTICLES |
SA Rollins, J Zhao, H Ninomiya and PJ Sims
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City 73104.
The capacity of the human complement regulatory protein CD59 to interact with terminal complement proteins in a species-selective manner was examined. When incorporated into chicken E, CD59 (purified from human E membranes) inhibited the cytolytic activity of the C5b-9 complex in a manner dependent on the species of origin of C8 and C9. Inhibition of C5b-9-mediated hemolysis was maximal when C8 and C9 were derived from human (hu) or baboon serum. By contrast, CD59 showed reduced activity when C8 and C9 were derived from dog or sheep serum, and no activity when C8 and C9 were derived from either rabbit or guinea pig (gp) serum. Similar specificity on the basis of the species of origin of C8 and C9 was also observed for CD59 endogenous to the human E membrane, using functionally blocking antibody against this cell surface protein to selectively abrogate its C5b-9-inhibitory activity. When E bearing human CD59 were exposed to C5b-8hu, CD59 was found to inhibit C5b-9-mediated lysis, regardless of the species of origin of C9, suggesting that the inhibitory function of CD59 can be mediated through recognition of species-specific domains expressed by human C8. Consistent with this interpretation, CD59 was found to bind to C5b-8hu but not to C5b67hu or C5b67huC8gp. Although CD59 failed to inhibit hemolysis mediated by C5b67huC8gpC9gp, its inhibitory function was observed for C5b67huC8gpC9hu, suggesting that, in addition to its interaction with C5b-8hu, CD59 also interacts in a species-selective manner with C9hu incorporated into C5b-9. Consistent with this interpretation, CD59 was found to bind both C5b67huC8gpC9hu and C5b- 8huC9gp, but not C5b67huC8gpC9gp. Taken together, these data suggest that the capacity of CD59 to restrict the hemolytic activity of human serum complement involves a species-selective interaction of CD59, which involves binding to both the C8 and C9 components of the membrane attack complex. Although CD59 expresses selectivity for C8 and C9 of human origin, this "homologous restriction" is not absolute, and this human complement regulatory protein retains functional activity toward C8 and C9 of some nonprimate species.
This article has been cited by other articles:
|
|
 |
|
  C. E. Soltani, E. M. Hotze, A. E. Johnson, and R. K. Tweten Structural elements of the cholesterol-dependent cytolysins that are responsible for their cholesterol-sensitive membrane interactions PNAS, December 18, 2007; 104(51): 20226 - 20231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Huang, F. Qiao, R. Abagyan, S. Hazard, and S. Tomlinson Defining the CD59-C9 Binding Interaction J. Biol. Chem., September 15, 2006; 281(37): 27398 - 27404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Tweten Cholesterol-Dependent Cytolysins, a Family of Versatile Pore-Forming Toxins Infect. Immun., October 1, 2005; 73(10): 6199 - 6209. [Full Text] [PDF]
|
|
|
|
|
|
M. Biedzka-Sarek, R. Venho, and M. Skurnik Role of YadA, Ail, and Lipopolysaccharide in Serum Resistance of Yersinia enterocolitica Serotype O:3 Infect. Immun., April 1, 2005; 73(4): 2232 - 2244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Zhang, P. H. H. Lopez, C. Y. Li, N. R. Mehta, J. W. Griffin, R. L. Schnaar, and K. A. Sheikh Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies Brain, May 1, 2004; 127(5): 1085 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Deng, D. Gold, P. T. LoVerde, and Z. Fishelson Inhibition of the Complement Membrane Attack Complex by Schistosoma mansoni Paramyosin Infect. Immun., November 1, 2003; 71(11): 6402 - 6410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pausa, V. Pellis, M. Cinco, P. G. Giulianini, G. Presani, S. Perticarari, R. Murgia, and F. Tedesco Serum-Resistant Strains of Borrelia burgdorferi Evade Complement-Mediated Killing by Expressing a CD59-Like Complement Inhibitory Molecule J. Immunol., March 15, 2003; 170(6): 3214 - 3222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Miwa, L. Zhou, B. Hilliard, H. Molina, and W.-C. Song Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack Blood, May 15, 2002; 99(10): 3707 - 3716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Margos, S. Navarette, G. Butcher, A. Davies, C. Willers, R. E. Sinden, and P. J. Lachmann Interaction between Host Complement and Mosquito-Midgut-Stage Plasmodium berghei Infect. Immun., August 1, 2001; 69(8): 5064 - 5071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Whitney and J. O. McNamara GluR3 Autoantibodies Destroy Neural Cells in a Complement-Dependent Manner Modulated by Complement Regulatory Proteins J. Neurosci., October 1, 2000; 20(19): 7307 - 7316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Adams, R. H. Chen, and A. Kadner Cardiac xenotransplantation: clinical experience and future direction Ann. Thorac. Surg., July 1, 2000; 70(1): 320 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Caliezi, W. A. Wuillemin, S. Zeerleder, M. Redondo, B. Eisele, and C. E. Hack C1-Esterase Inhibitor: An Anti-Inflammatory Agent and Its Potential Use in the Treatment of Diseases Other Than Hereditary Angioedema Pharmacol. Rev., March 1, 2000; 52(1): 91 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-f. Zhang, J. Yu, S. Chen, B. P. Morgan, R. Abagyan, and S. Tomlinson Identification of the Individual Residues That Determine Human CD59 Species Selective Activity J. Biol. Chem., April 16, 1999; 274(16): 10969 - 10974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hakulinen and S. Meri Complement-Mediated Killing of Microtumors in Vitro Am. J. Pathol., September 1, 1998; 153(3): 845 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-j. Zhao, J. Zhao, Q. Zhou, and P. J. Sims Identity of the Residues Responsible for the Species-restricted Complement Inhibitory Function of Human CD59 J. Biol. Chem., April 24, 1998; 273(17): 10665 - 10671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Hinchliffe, N. K. Rushmere, S. M. Hanna, and B. P. Morgan Molecular Cloning and Functional Characterization of the Pig Analogue of CD59: Relevance to Xenotransplantation J. Immunol., April 15, 1998; 160(8): 3924 - 3932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Rabesandratana, J.-P. Toutant, H. Reggio, and M. Vidal Decay-Accelerating Factor (CD55) and Membrane Inhibitor of Reactive Lysis (CD59) Are Released Within Exosomes During In Vitro Maturation of Reticulocytes Blood, April 1, 1998; 91(7): 2573 - 2580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Makrides Therapeutic Inhibition of the Complement System Pharmacol. Rev., March 1, 1998; 50(1): 59 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yu, R. Abagyan, S. Dong, A. Gilbert, V. Nussenzweig, and S. Tomlinson Mapping the Active Site of CD59 J. Exp. Med., February 17, 1997; 185(4): 745 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Bodian, S. J. Davis, B. P. Morgan, and N. K. Rushmere Mutational Analysis of the Active Site and Antibody Epitopes of the Complement-inhibitory Glycoprotein, CD59 J. Exp. Med., February 3, 1997; 185(3): 507 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Rother, J. Zhao, Q. Zhou, and P. J. Sims Elimination of Potential Sites of Glycosylation Fails to Abrogate Complement Regulatory Function of Cell Surface CD59 J. Biol. Chem., September 27, 1996; 271(39): 23842 - 23845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Lockert, K. M. Kaufman, C.-P. Chang, T. Hüsler, J. M. Sodetz, and P. J. Sims Identity of the Segment of Human Complement C8 Recognized by Complement Regulatory Protein CD59 J. Biol. Chem., August 25, 1995; 270(34): 19723 - 19728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hüsler, D. H. Lockert, K. M. Kaufman, J. M. Sodetz, and P. J. Sims Chimeras of Human Complement C9 Reveal the Site Recognized by Complement Regulatory Protein CD59 J. Biol. Chem., February 24, 1995; 270(8): 3483 - 3486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Farkas, L. Baranyi, Y. Ishikawa, N. Okada, C. Bohata, D. Budai, A. Fukuda, M. Imai, and H. Okada CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9 J. Physiol., March 1, 2002; 539(2): 537 - 545. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
